{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-000403","form_type":"8-K","ticker":"RDNT","cik":"0000790526","company_name":"RadNet, Inc.","filed_at":"2022-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.777523+00:00","generated_at":"2026-06-27T16:22:02.217948+00:00","sec_items":["3.02","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"RadNet acquires AI firms Aidence and Quantib for ~$95M combined; issues 2.1M shares","bullets":["Aidence acquired for ~$50M (incl. $10M milestones); Quantib for ~$45M.","Issued 1,141,234 shares for Aidence and 965,058 shares for Quantib to stakeholders.","Adds AI for lung nodule (Aidence) and prostate/brain MRI (Quantib) to DeepHealth division.","Quantib products have FDA 510(k) clearance; Aidence's Veye pending FDA approval.","Dr. Gregory Sorensen to lead combined AI initiatives across all three entities."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-000403","json":"https://secwatch.observer/filing/0001683168-22-000403.json","markdown":"https://secwatch.observer/filing/0001683168-22-000403.md","text":"https://secwatch.observer/filing/0001683168-22-000403.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/790526/000168316822000403/0001683168-22-000403-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/790526/000168316822000403/radnet_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:22:02.217948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}